[1. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51: 6304-11.]Search in Google Scholar
[2. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 1992; 89: 7491-5.10.1073/pnas.89.16.7491]Search in Google Scholar
[3. Howard A, Pelc SR. Synthesis of deoxyribonucleic acid in normal and irradiated cells and its relation to chromosome breakage. Heredity 1953; 6: 261-73.]Search in Google Scholar
[4. Little JB. Delayed initiation of DNA synthesis in irradiated human diploid cells. Nature 1968; 218: 1064-5.10.1038/2181064a0]Search in Google Scholar
[5. Cuddihy AR, Bristow RG. The p53 protein family and radiation sensitivity: Yes or no? Cancer Met Rev 2004; 23: 237-57.]Search in Google Scholar
[6. Zölzer F, Streffer C. Quiescence in S-phase and G1 arrest induced by irradiation and/or hyperthermia in six human tumour cell lines of different p53 status. Int J Radiat Biol 2000; 76: 717-25.10.1080/095530000138394]Search in Google Scholar
[7. Terasima T, Tolmach LJ. Variations in several responses of HeLa cells to xirradiation during the division cycle. Biophys J 1963; 3: 11-33.10.1016/S0006-3495(63)86801-0]Search in Google Scholar
[8. Zölzer F, Jagetia G, Streffer C. G2-block after irradiation of cells with different p53 status. Strahlen Onkol, June 14 2014. [Epub ahead of print]. doi 10.1007/s00066-014-0690-510.1007/s00066-014-0690-5]Search in Google Scholar
[9. Agarwal ML, Agarwal A, Taylor WR, Stark GR. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 1995; 92: 8493-7.10.1073/pnas.92.18.8493]Search in Google Scholar
[10. Stewart N, Hicks GG, Paraskevas F, Mowat M. Evidence for a second cell cycle block at G2/M by p53. Oncogene 1995; 10: 109-15.]Search in Google Scholar
[11. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 282: 1497-501.10.1126/science.282.5393.1497]Search in Google Scholar
[12. Solberg Landsverk K, Patzke S, Rein ID, Stokke C, Lyng H, De Angelis PM, Stokke T. Three independent mechanisms for arrest in G2 after ionizing radiation. Cell Cycle 2011; 10: 819-29.10.4161/cc.10.5.14968]Search in Google Scholar
[13. Taylor WR, Stark GR. Regulation of the G2/M transition by p53. Oncogene 2001; 20: 1803-15.10.1038/sj.onc.1204252]Search in Google Scholar
[14. Stark GR, Taylor WR. Control of the G2/M transition. Mol Biotech 2006; 32: 227-48.10.1385/MB:32:3:227]Search in Google Scholar
[15. Busse PM, Bose SK, Jones RW, Tolmach LJ. The action of caffeine on X-irradiated HeLa cells. III. Enhancement of X-ray-induced killing during G2 arrest. Radiat Res 1978; 76: 292-307.10.2307/3574780]Search in Google Scholar
[16. Powell SN, DeFrank JS, Connell P, Eogan M, Preffer F, Dombkowski D, et al. Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res 1995; 55: 1643-8.10.1016/0360-3016(95)97825-L]Search in Google Scholar
[17. Musk SR. Reduction of radiation-induced cell cycle blocks by caffeine does not necessarily lead to increased cell killing. Radiat Res 1991; 125: 262-6.10.2307/3578108]Search in Google Scholar
[18. Schwartz JL, Cowan J, Grdina DJ, Weichselbaum RR. Attenuation of G2- phase cell cycle checkpoint control is associated with increased frequencies of unrejoined chromosome breaks in human tumor cells. Radiat Res 1996; 146: 139-43.10.2307/3579585]Search in Google Scholar
[19. Iliakis G, Wang Y, Guan J, Wang H. DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 2003; 22: 5834-47.10.1038/sj.onc.1206682]Search in Google Scholar
[20. Painter RB, Young BR. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc Natl Acad Sci USA 1980; 77: 7315-710.1073/pnas.77.12.7315]Search in Google Scholar
[21. Larner JM, Lee H, Hamlin JL. S phase damage sensing checkpoints in mammalian cells. Cancer Surv 1997; 29: 25-45.]Search in Google Scholar
[22. Morgan SE, Lovly C, Pandita TK, Shiloh Y, Kastan MB. Fragments of ATM which have dominant-negative or complementing activity. Mol Cell Biol 1997; 17: 2020-9.10.1128/MCB.17.4.2020]Search in Google Scholar
[23. Fei P, El-Deiry WS. P53 and radiation responses. Oncogene 2003; 22: 5774-83.10.1038/sj.onc.1206677]Search in Google Scholar
[24. Bartek J, Lukas C, Lukas J. Checking on DNA damage in S phase. Nature Rev Mol Cell Biol 2004; 5: 792-804.10.1038/nrm1493]Search in Google Scholar
[25. Liu WF, Yu SS, Chen GJ, Li YZ. DNA damage checkpoint, damage repair, and genome stability. Acta Gen Sin 2006; 33: 381-90.10.1016/S0379-4172(06)60064-4]Search in Google Scholar
[26. Lee AY, Chiba T, Truong LN, Cheng AN, Do J, Cho MJ, et al. Dbf4 is direct downstream target of ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3-related (ATR) protein to regulate intra-S-phase checkpoint. J Biol Chem 2012; 287: 2531-43.10.1074/jbc.M111.291104]Search in Google Scholar
[27. Falck J, Petrini JH, Williams BR, Lukas J, Bartek J. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nature Gen 2002; 30, 290-4.10.1038/ng845]Search in Google Scholar
[28. Willis N, Rhind N. Regulation of DNA replication by the S-phase DNA damage checkpoint. Cell Div 2009; 4: 13.10.1186/1747-1028-4-13]Search in Google Scholar
[29. Dai Y, Grant S. New insights into checkpoint kinase 1 in the DNA damage response signaling network. Clin Cancer Res 2010; 16: 376-83.10.1158/1078-0432.CCR-09-1029]Search in Google Scholar
[30. Yazdi PT, Wang Y, Zhao S, Patel N, Lee EY, Qin J. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev 2002; 16: 571-82.10.1101/gad.970702]Search in Google Scholar
[31. Luo H, Li Y, Mu JJ, Zhang J, Tonaka T, Hamamori Y, et al. Regulation of intra-S phase checkpoint by ionizing radiation (IR)-dependent and IR-independent phosphorylation of SMC3. J Biol Chem 2008; 283: 19176-83.10.1074/jbc.M802299200]Search in Google Scholar
[32. Zhou XY, Wang X, Hu B, Guan J, Iliakis G, Wang Y. An ATM-independent S-phase checkpoint response involves CHK1 pathway. Cancer Res 2002; 62: 1598-603.]Search in Google Scholar
[33. Sørensen CS, Syljuåsen RG, Falck J, Schroeder T, Rönnstrand L, Khanna KK, Zhou BB, Bartek J, Lukas J. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 2003; 3: 247-58.10.1016/S1535-6108(03)00048-5]Search in Google Scholar
[34. Cho YJ, Liang P. Killin is a p53-regulated nuclear inhibitor of DNA synthesis. Proc Natl Acad Sci USA 2008; 105: 5396-401.10.1073/pnas.0705410105229108018385383]Search in Google Scholar
[35. Cho YJ, Liang P. S-phase-coupled apoptosis in tumor suppression. Cell Mol Life Sci 2008; 68: 1883-96.]Search in Google Scholar
[36. Demidova AR, Aau MY, Zhuang L, Yu Q. Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control. J Biol Chem 2009; 284: 4132-9.10.1074/jbc.M80811820019060337]Search in Google Scholar
[37. Vigneron A, Cherier J, Barré B, Gamelin E, Coqueret O. The cell cycle inhibitor p21waf1 binds to the myc and cdc25A promoters upon DNA damage and induces transcriptional repression. J Biol Chem 2006; 281: 34742-50.10.1074/jbc.M60249220016923815]Search in Google Scholar
[38. Zhu Y, Alvarez C, Doll R, Kurata H, Schebye XM, Parry D, Lees E. Intra-S-phase checkpoint activation by direct CDK2 inhibition. Mol Cell Biol 2004; 24: 6268-77.10.1128/MCB.24.14.6268-6277.2004]Search in Google Scholar
[39. Weininger J, Guichard M, Joly AM, Malaise EP, Lachet B. Radiosensitivity and growth parameters in vitro of three human melanoma cell strains. Int J Radiat Biol 1978; 34: 285-90.]Search in Google Scholar
[40. Fogh J, Bean MA, Brüggen J, Fogh H, Fogh JM, Hammar SP, et al. Comparison of a human tumor cell line before and after growth in the nude mouse. In: Fogh J, Giovanella B, editors. The nude mouse in experimental and clinical research. New York: Academic Press; 1978. p. 215-45.]Search in Google Scholar
[41. Zölzer F, Hillebrandt S, Streffer C. Radiation induced G1-block and p53 status in six human cell lines. Radiother Oncol 1995; 37: 20-8.10.1016/0167-8140(95)01618-Q]Search in Google Scholar
[42. Albino AP, Vidal MJ, McNutt NS, Shea CR, Prieto VG, Nanus DM, et al. Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res 1994; 4: 35-45.10.1097/00008390-199402000-00006]Search in Google Scholar
[43. Böhnke A, Westphal F, Schmidt A, El-Awady RA, Dahm-Daphi J. Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumour cells. Int J Radiat Biol 2004; 80: 53-63.10.1080/09553000310001642902]Search in Google Scholar
[44. Binder AB, Serafin AM, Bohm LJ. Abrogation of G(2)/M-phase block enhances the cytotoxicity of daunorubicin, melphalan and cisplatin in TP53 mutant human tumor cells. Radiat Res 2000; 154: 640-9.10.1667/0033-7587(2000)154[0640:AOGMPB]2.0.CO;2]Search in Google Scholar
[45. Stuschke M, Budach V, Sack H. Radioresponsiveness of human glioma, sarcoma, and breast cancer spheroids depends on tumour differentiation. Int J Radiat Oncol Biol Phys 1993; 27: 627-36.10.1016/0360-3016(93)90389-D]Search in Google Scholar
[46. Wurm R, Ketel B, Schröder G, Sinn B, Schlenger L, Wolf G, et al. Strahlenempfindlichkeit nach kombination von bestrahlung und koffein. Strahlenther Onkol 1997; 173: 614.]Search in Google Scholar
[47. Zölzer F, Uma Devi P, Streffer C. Determination of potential doubling times in human melanoma cell cultures subjected to irradiation and/or hyperthermia by flow cytometry. Radiat Res 1994; 138: 451-9.10.2307/3578695]Search in Google Scholar
[48. Zölzer F, Streffer C, Pelzer T. Induction of quiescent S-phase cells by irradiation and/or hyperthermia. I. Time and dose dependence. Int J Radiat Biol 1993; 63: 69-76.10.1080/09553009314550091]Search in Google Scholar
[49. Begg AC, Moonen L, Hofland I, Dessing M, Bartelink H. Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations. Radiother Oncol 1988; 11: 337-47.10.1016/0167-8140(88)90205-8]Search in Google Scholar
[50. Zölzer F, Streffer C. G2-phase delays after irradiation and/or heat treatment as assessed by two-parameter flow cytometry. Radiat Res 2001; 155: 50-6.10.1667/0033-7587(2001)155[0050:GPDAIA]2.0.CO;2]Search in Google Scholar
[51. Zhou J, Prives C. Replication of damaged DNA in vitro is blocked by p53. Nucl Acid Res 2003; 31: 3881-92.10.1093/nar/gkg46816598212853603]Search in Google Scholar
[52. Mirzayans R, Aubin RA, Bosnich W, Blattner WA, Paterson MC. Abnormal pattern of post-γ-ray DNA replication in radioresistant fibroblast strains from affected members of a cancer-prone family with Li-Fraumeni syndrome. Br J Cancer 1995; 71: 1221-30. 10.1038/bjc.1995.23720338547779715]Search in Google Scholar